Analystreport

Rhythm Pharmaceuticals Inc (NASDAQ: RYTM) was given a new $42.00 price target on by analysts at Needham & Company LLC. They now have a "buy" rating on the stock.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com